Abstract
Lower respiratory tract infections (LRTIs) from Respiratory Syncytial Virus (RSV) are due, in part, to secreted signals from lower airway cells that modify immune response and trigger airway remodeling. To understand this process, we applied an unbiased quantitative proteomics analysis of the RSV-induced epithelial secretory response in cells representative of the trachea (hBECs) vs small airway bronchiolar cells (hSAECs). A workflow was established using telomerase- immortalized human epithelial cells that revealed highly reproducible cell type-specific differences in both secreted proteins and nanoparticles (exosomes). Approximately one-third of secretome proteins are exosomal, with the remainder from lysosomal and vacuolar compartments. We applied this workflow to three independently derived primary human cultures from trachea (phBECs) vs bronchioles (phSAECs). 577 differentially expressed proteins from control supernatants and 966 differentially expressed proteins from RSV-infected cell supernatants were identified at a 1% false discovery rate (FDR). Fifteen proteins unique to RSV-infected phBECs were regulated by epithelial-specific ets homology factor (EHF). 106 proteins unique to RSV-infected hSAECs were regulated by the transcription factor NFκB. In this latter group, we validated the differential expression of Chemokine (C-C Motif) Ligand 20 (CCL20)/macrophage-inducible protein (MIP)3α, thymic stromal lymphopoietin (TSLP) and chemokine (CC) ligand 3-like 1(CCL3-L1) because of their roles in Th2 polarization. CCL20/MIP3α was the most active mucin-inducing factor in the RSV-infected hSAEC secretome, and was differentially expressed in smaller airways in a mouse model of RSV infection. These studies provide insights into the complexity of innate responses, and regional differences in epithelial secretome participating in RSV LRTI-induced airway remodeling.
Keywords: Airway Epithelial Cells, label-free proteomics, Chemokine (C-C Motif) Ligand 20 (CCL20), macrophage-inducible protein (MIP)3α, Thymic Stromal Lymphopoietin
Introduction
Human Respiratory Syncytial Virus (RSV) is a ubiquitous paramyxovirus pathogen that infects virtually all children by the age of 3, causing significant morbidity (1, 2). The presence of RSV infection produces 3-times the risk of subsequent hospitalization over that seen in infections with other common cold viruses, and hospitalization rates as high as of 17 per 1000 cases are seen in prospective epidemiological studies on young children (3).
RSV infections produce a variety of clinical syndromes including upper respiratory tract infections (with or without recurrent otitis media) and lower respiratory tract infections [LRTIs (1, 4)]. Although the majority of infections produce an uncomplicated URI, in ~2% of predisposed children RSV can spread into the lower airways, producing LRTI (1, 5, 6). RSV is consequently the most common cause of childhood LRTIs (7), responsible for 120,000 hospitalizations for LRTI (bronchiolitis) in the US annually (8), and represents the leading cause of infant viral death worldwide (9). Apart from its acute morbidity, severe LRTIs are associated with reshaping the pulmonary immune response, producing Th2 polarization and enhancing susceptibility to recurrent virus-induced wheezing through the next several decades of life (10). The mechanisms by which LRTIs reprogram the pulmonary immune system are not fully understood.
As a mucosa-restricted virus, in natural infections RSV initially replicates in the epithelium of the nasopharynx. In immunologically naïve infants, RSV spreads by cell-cell transfer and extracellular binding, producing discontinuous foci of infection in the tracheal epithelium (11). Further spread of RSV infection to distal bronchioles and the alveolar epithelium induces necrosis and sloughing. Sloughed epithelial cells are encased in fibrin and mucin, producing a ball-valve obstruction and ventilation-perfusion mismatching, impairing gas exchange and causing hypoxia, one of the most significant clinical features of LRTIs. The mechanism by which RSV produces epithelial sloughing has recently been partly elucidated: the intracellular expression of RSV nonstructural (NS) protein NS2 disrupts ciliary tubulin IV, obliterating epithelial ciliary function and inducing detachment from the basal lamina (12).
Because RSV LRTI occurs in immunologically naïve infants, the innate immune response plays an initiating role in LRTI pathogenesis. It has been extensively demonstrated that RSV replication in epithelial cells triggers a coordinated global genomic response that results in epithelial secretion of mucins, defensins, antiviral cytokines and proinflammatory chemokines that coordinate inflammation and adaptive immunity (13–15). Enhanced activation of innate inflammation has been demonstrated in children with bronchiolitis, where enhanced expression of IL-6, -8 and MIP-1β have been observed (16). Important to the pathogenesis of LRTI, the epithelium in the proximal conductive airways and the respiratory surface play functionally distinct roles in innate defenses (17, 18). Under normal conditions, inhaled pathogens are cleared via the mucociliary escalator from ciliated epithelial cells. This defense is coordinated with the actions of the airway lining fluid, rich in antioxidants, defensins, and lysozyme secreted by clara cells and submucosal glands and that of mucous glycoprotein secreted by goblet cells (19). When these conductive epithelial cells are infected with RSV, they secrete CXCL chemokines macrophage inhibitory protein (MIP)-1 and type I/III interferons (IFNs). These latter cytokines activate resident plasmacytoid dendritic cells (DCs) to upregulate CD-40, -80 and -86 co-stimulatory molecules, inducing their migration to draining lymph nodes to stimulate cytotoxic T lymphocytes, which include natural killer and CD4/8+ memory T cells (17).
By contrast, when nonciliated epithelial cells located in the conductive airways (terminal bronchioles and alveoli) are infected with RSV, they express the CCL-type cytokines (TARC, MCP-1, and MDC), type I/III IFNs, and surfactants (15). These factors activate alveolar macrophages and pulmonary DCs (pDCs) to induce neutrophil recruitment and promote macrophage survival. Gene profiling experiments have suggested that these CCL-type chemokines are produced to a greater degree than by epithelial cells of the conducting airways (20). These findings suggest the presence of distinct regional, cell type-specific differences between activated conductive vs respiratory epithelial cells that may be immunologically important (15, 20). Despite this knowledge, there has been no systematic analysis of secreted proteins that would provide an understanding of the distinct mechanisms of innate immunity in different regions of the pulmonary tree.
To address this deficiency, we undertook a systematic analysis of RSV-induced secreted proteins in two principal cell types of the airways – bronchial epithelial cells (hBECs), derived from the trachea and representing the conducting portion of the airway, vs nonciliated small airway epithelial cells (hSAECs), representing nonciliated cells from terminal bronchioles that play a role in lower airway obstruction in RSV LRTIs (21). We first standardized a workflow by analysis of control and RSV-induced conditioned medium (CM) in telomerase (Tert)-immortalized hSAECs and hBECs, using quantitative label-free mass spectrometry. Our analysis was highly reproducible and identified distinct patterns of induced and inhibited proteins. Interestingly, exosomes constituted a significant fraction of the secretome; their protein contents also differed by cell type and were affected by RSV infection. We extended this workflow to analyze multiple non-immortalized primary cells from independent donors. Strikingly, hSAECs showed enhanced expression of immunologically important chemokines – CCL20/MIP3α, TSLP and CCL3-L1. We demonstrate that CCL20/MIP3α is the most active mucin-inducing factor in RSV CM from hSAECs, and discuss the implications of regional differences in the epithelial secretome for the pathogenesis of LRTIs.
Materials and Methods
Cell culture and treatment
Immortalized human bronchial epithelial cells (tert-hBECs) and small airway epithelial cells (tert-hSAECs) were established by transducing primary cells with human telomerase and cyclin- dependent kinase (CDK)-4 retrovirus constructs (22, 23). hBECs and hSAECs were grown in basal medium supplemented with growth factors (Lonza, Walkersville) in 10 cm Petri dishes in a humidified incubator with 95% air/5% CO2 at 37 °C. At 80–90% confluence, the medium was changed, fresh basal medium without growth supplements was added to the plates, and the cells infected with pRSV (MOI 1.0) for 24h. Conditioned Medium (CM) was collected and centrifuged at 2000 x g at 4 °C for 20 min to remove any dead cells. The supernatant was centrifuged at 10,000 x g at 4 °C for 10 min to remove any cell debris. The supernatant was used immediately for secretome analysis. Cells from the same plates were lysed in Trizol for whole- cell protein preparation. Experiments were performed in biological triplicates.
For studies with primary human bronchial epithelial cells (phBECs) and phSAECs, cells from three different donors were obtained from Lonza (Supplemental Table I). CM was prepared from hBECs or hSAECs 24 h post-infection (MOI=1.0). When indicated, CM for UV-inactivated RSV-infected cells was used to stimulate hBECs at a 1–25% (vol/vol) concentration for the indicated times. UV inactivation was as previously described (24). For antibody neutralization, 20 μL of RSV-CM was mixed with anti-CCL20 Ab (R&D Systems, Minneapolis, MN).
Exosome preparation
Exosome isolation was performed by differential centrifugation at +4 °C to minimize protein degradation. Cells were removed by low-speed centrifugation at 400 x g, 10 min. The cleared supernatant was then sequentially centrifuged at 2000 x g for 15 min and 10,000 x g for 30 min to remove any remaining cell debris/microvesicles. Exosomes were finally pelleted by ultracentrifugation at 100,000 x g for 2 h and washed in PBS (without Ca++ or Mg++) at 100,000 x g, 60 min. After washing, the pellet was resuspended in a total of 200 μL of PBS. Exosome size was estimated by dynamic light scattering using a Malvern High-Performance Particle Sizer (Malvern Instruments, Westborough MA). Data acquisition and analysis were performed using Dispersion Technology Software (DTS, V4.1.26.0) configured for HPPS analysis. Each experimental group had three independent replicates.
Preparation of sucrose cushion-purified RSV (pRSV)
The human RSV A2 strain was grown in Hep-2 cells and prepared by sucrose cushion centrifugation as described (50). The viral titer was determined by a methylcellulose plaque assay. pRSV aliquots were quick-frozen in dry ice-ethanol, and stored at −70 °C until use.
Immunofluorescence (IF) microscopy
Airway cells were plated on cover glasses pretreated with rat tail collagen (Roche Applied Sciences). The cells were fixed with 4 % paraformaldehyde in PBS, permeabilized with 0.1% Triton X-100, blocked in 10% goat serum, and incubated with primary rabbit polyclonal Ab to cytokeratin-7 or 19 as indicated (25, 26). After incubation with Alexa-goat anti-Rb Ab, cells were washed and counterstained with 4′,6-diamidino-2-phenylindole (DAPI). The cells were visualized with a Zeiss fluorescence LSM510 confocal microscope at 63x magnification.
IF of paraffin-embedded mouse lung was performed following standard protocols. Briefly, lung sections (5-μm) were deparaffinized in xylene and hydrated in ethanol (100% – 70%). Sections were washed with deionized water. Antigen unmasking was done with 1.0 mM EDTA, pH8.0. Sections were washed in H2O and blocked with 10% goat serum for 1 h at room temperature in the dark, followed by primary antibody against CCL20 (1:200 dilution, Abcam) overnight at 4 °C in the dark. Sections were washed with TBS-Tween (0.1%) buffer and incubated with goat secondary Ab conjugated with Alexa 568 (DAKO) for 1h at room temperature in the dark. Sections were washed in TBS-Tween (0.1%), incubated with DAPI for 1 min, mounted on coverslips and visualized by confocal microscopy (Zeiss) and photographed at 63x magnification.
Apoptosis assay
Apoptosis was measured using a commercial annexin V-FITC apoptosis detection kit following the manufacturer’s protocol (BioVision, Milpitas, CA). Briefly, hBEC and hSAEC cells (1x106) were infected with or without RSV (MOI 1.0) for 24h. Cells were dislodged with Accutase (Millipore), washed once with PBS and incubated with 5 μL of annexin V-FITC and 5 μL of Propidium Iodide (PI) in 500 μL of binding buffer for 5 min at room temperature in the dark. Annexin V-FITC and PI labeling was measured by flow cytometry.
Transmission Electron Microscopy (TEM)
A 10 μL aliquot from the exosome suspension was diluted in deionized water, applied to 200 mesh Formvar/carbon coated copper grids (Electron Microscopy Sciences) for 10 min at room temperature (24 °C) and negatively stained with 2% uranyl acetate (UA). The grids were examined in a Philips CM-100 transmission electron microscope at 60 kV FEI (Thermo-Fischer). Exosome images were acquired with a Gatan Orius 2001 charge-coupled device (CCD) camera.
Secretome digestion
About 10 mL of the CM supernatant was added into a 3K filter unit (Millipore, Billerica, MA) and centrifuged at 14,000 x g for 15 min. 400 μL of 8 M urea was added into the filter unit and centrifuged at 14,000 x g for 15 min, and this step repeated once. The solution remaining in the filter device was collected for protein digestion. Proteins were reduced with 10 mM dithiothreitol for 30 min, followed by alkylation with 30 mM iodoacetamide for 60 min in the dark. The sample was diluted 1:1 with 50 mM ammonium bicarbonate. Proteins were digested with 1.0 μg LysC-tr (Promega) for 12 h at 37 °C and then diluted 4:1 with 50 mM ammonium bicarbonate. The proteins were further digested with 1.0 μg trypsin (Promega) for 16 h at 37 °C. The digestion was stopped with 0.5 % trifluoracetic acid (TFA) and the peptides desalted on a reversed-phase SepPak C18 cartridge (Waters); peptides were eluted using 80% acetonitrile (ACN). The eluate was dried in a SpeedVac and the peptides acidified with 2% ACN-0.1% TFA.
Cellular proteome digestion
About 50 μg of proteins in 8 M guanidine were reduced with 10 mM dithiothreitol, alkylated with 30 mM iodoacetamide, sequentially digested with 1.0 μg LysC-tr and 1.0 μg trypsin as described above for secretome proteins.
Exosome digestion
The proteins present in the exosomes were separated from the lipid components by chloroform/methanol precipitation (27). After resuspension of the chloroform/methanol precipitation pellet in 45 μL of 8 M guanidine, proteins were reduced with DTT, alkylated with iodoacetamide, and sequentially digested with LysC-tr and trypsin as described above.
LC-MS/MS analysis
A nanoflow UHPLC instrument (Easy nLC, Thermo Fisher Scientific) was coupled on-line to a Q Exactive mass spectrometer (Thermo Fisher Scientific) with a nanoelectrospray ion source (Thermo Fisher Scientific). Peptides were loaded onto a C18 reversed-phase column (25 cm long, 75 μm inner diameter) and separated with a linear gradient of 5–35% buffer B (100% acetonitrile in 0.1% formic acid) at a flow rate of 300 nL/min over 240 min. MS data were acquired using a data-dependent Top15 method dynamically choosing the most abundant precursor ions from the survey scan (400–1400 m/z) using HCD fragmentation. Survey scans were acquired at a resolution of 70,000 at m/z 400. Unassigned precursor ion charge states as well as singly charged species were excluded from fragmentation. The isolation window was set to 3 Da and fragmented with a normalized collision energy of 27. The maximum ion injection times for the survey scan and the MS/MS scans were 20 ms and 60 ms, respectively, and the ion target values were set to 1e6 and 1e5, respectively. Selected sequenced ions were dynamically excluded for 30 seconds. Data were acquired using Xcalibur software (Thermo).
Data processing and bioinformatic analysis
Mass spectra were analyzed using MaxQuant software version 1.5.2.8 using the Andromeda search engine (28, 29). The initial maximum allowed mass deviation was set to 10 ppm for monoisotopic precursor ions and 0.5 Da for MS/MS peaks. Enzyme specificity was set to trypsin, defined as C-terminal to arginine and lysine excluding proline, and a maximum of two missed cleavages were allowed. Carbamidomethylcysteine was set as a fixed modification, and N-terminal acetylation and methionine oxidation as variable modifications. The spectra were searched with the Andromeda search engine against the Human and RSV SWISSPROT sequence database (containing 20,193 human protein entries and 11 RSV protein entries) combined with 248 common contaminants, and concatenated with the reversed versions of all sequences. Protein identification required at least one unique or razor peptide per protein group. Quantification in MaxQuant was performed using the built in XIC-based label-free quantification (LFQ) algorithm (29). The required false discovery rate (FDR) for identification was set to 1% at the peptide and 1% at the protein level, and the minimum required peptide length to 6 amino acids. Contaminants, reverse identification and proteins only identified by site were excluded from further data analysis. The raw data, and database search results are deposited in ProteomeXchange (http://www.proteomexchange.org/) under Project Accession Number PXD005814. For comparative analysis, the LFQ values were log2-transfomed. After filtering (at least 2 valid LFQ values in at least one group), remaining missing LFQ values were imputed from a normal distribution (width: 0.3; down shift: 1.8). Significance analysis of microarrays (SAM) was used to assess the statistical significance of protein abundances using 1% FDR adjustment and a two-fold cutoff (30).
The normalized spectral abundance factor (NSAF) value for each protein was calculated as
where the total MS intensity (I) of the matching peptides from protein k was divided by the protein length (L) and then by the sum of I/L for all uniquely identified proteins in the dataset (31).
For pairwise comparisons, missing NSAF values for proteins that were only present in either CM or the whole-cell lysate (WCL) were imputed from a normal distribution (width: 0.3; down shift: 1.8). For principal component analysis, unsupervised hierarchical clustering, GO annotation enrichment, and Fisher’s exact tests, we used the Perseus bioinformatics platform (http://141.61.102.17/perseus_doku/doku.php?id=start). We used Ingenuity Pathways Analysis (IPA) for upstream regulator analysis. Gene set enrichment analysis was performed by quantifying canonical pathway enrichment (32). Exosome analyses were performed by searching the ExoCarta exosome database at http://www.exocarta.org/ (33).
Stable isotope dilution (SID)-selected reaction monitoring (SRM)-MS
The SID-SRM-MS assays were developed as described previously (34). The peptides were chemically synthesized incorporating isotopically labeled [13C615N4] arginine or [13C615N2] lysine to a 99% isotopic enrichment (Thermo Scientific). The secretome and cellular proteome were digested as described above. The tryptic digests were reconstituted in 30 μL of 5% formic acid/0.01% TFA. An aliquot of 10 μL of diluted stable isotope-labeled standard (SIS) peptides was added to each tryptic digest. These samples were desalted with a ZipTip C18 cartridge; the peptides were eluted with 80% can, dried, reconstituted in 30 μL of 5% formic acid/0.01% TFA, and directly analyzed by liquid chromatography (LC)-SRM-MS using a TSQ Vantage triple quadrupole mass spectrometer equipped with a nanospray source (Thermo Scientific, San Jose, CA). Online chromatography was performed using an Eksigent NanoLC-2D HPLC system (AB SCIEX, Dublin, CA). An aliquot of 10 μL of each tryptic digest was injected onto a C18 reversed-phase nano-HPLC column (PicoFrit™, 75 μm x 10 cm; tip ID 15 μm) at a flow rate of 500 nL/min with a 20-min 98% A, followed by a 15-min linear gradient from 2–30% mobile phase B (0.1 % formic acid/90% acetonitrile) in mobile phase A (0.1 % formic acid). The TSQ Vantage was operated in high-resolution SRM mode with Q1 and Q3 set to 0.2 and 0.7-Da Full Width Half Maximum (FWHM). All acquisition methods used the following parameters: 1800 V ion spray voltage, a 275°C ion transferring tube temperature, a collision-activated dissociation pressure at 1.5 mTorr, and the S-lens voltage used the values in the S-lens table generated during MS calibration.
All SRM data were manually inspected to ensure peak detection and accurate integration. The chromatographic retention time and the relative product ion intensities of the analyte peptides were compared to those of the SIS peptides. The variation of the retention time between the analyte peptides and their SIS counterparts should be within 0.05 min, and no significant differences in the relative product ion intensities of the analyte peptides and SIS peptides were observed. The peak areas in the extract ion chromatography of the native and SIS version of each signature peptide were integrated using Xcalibur® 2.1. The default values for noise percentage and baseline subtraction window were used. The ratios between the peak area of the native and SIS versions of each peptide were calculated.
Quantitative Real Time PCR (Q-RT-PCR)
For gene expression analyses, 1 μg of RNA was reverse-transcribed using Super Script III in a 20 μL reaction mixture (34). One μL of cDNA product was diluted 1:2, and 2 μL of diluted product was amplified in a 20 μL reaction mixture containing 10 μL of SYBR Green Supermix (Bio-Rad) and 0.4 μM each of forward and reverse gene-specific primers (Table I). The reaction mixtures were aliquoted into a Bio-Rad 96-well clear PCR plate and the plate sealed with Bio-Rad Microseal B film before insertion into the PCR machine. The plates were denatured for 90 s at 95°C and then subjected to 40 cycles of 15 s at 94°C, 60 s at 60°C, and 1 min at 72°C in an iCycler (Bio-Rad). PCR products were subjected to melting curve analysis to assure that a single amplification product was produced. Quantification of relative changes in gene expression was calculated using the ΔΔCt method (26). Data were expressed as fold change mRNA normalized to cyclophilin or PolB mRNA abundance as indicated as an internal control.
Table I.
hBEC-Control | Replicate 1 | Replicate 2 | Replicate 3 | Replicate 4 |
---|---|---|---|---|
Replicate 1 | 0.876 | 0.865 | 0.861 | |
Replicate 2 | 0.876 | 0.858 | 0.863 | |
Replicate 3 | 0.865 | 0.858 | 0.852 | |
Replicate 4 | 0.861 | 0.863 | 0.852 | |
Mean ± SD | 0.863 ± 0.008 | |||
hBEC-RSV | Replicate 1 | Replicate 2 | Replicate 3 | Replicate 4 |
Replicate 1 | 0.955 | 0.959 | 0.95 | |
Replicate 2 | 0.955 | 0.958 | 0.956 | |
Replicate 3 | 0.959 | 0.958 | 0.966 | |
Replicate 4 | 0.95 | 0.956 | 0.966 | |
Mean ± SD | 0.957 ± 0.005 | |||
hSAEC-Control | Replicate 1 | Replicate 2 | Replicate 3 | Replicate 4 |
Replicate 1 | 0.866 | 0.86 | 0.859 | |
Replicate 2 | 0.866 | 0.88 | 0.86 | |
Replicate 3 | 0.86 | 0.88 | 0.851 | |
Replicate 4 | 0.859 | 0.86 | 0.851 | |
Mean ± SD | 0.863 ± 0.010 | |||
hSAEC- RSV | Replicate 1 | Replicate 2 | Replicate 3 | Replicate 4 |
Replicate 1 | 0.934 | 0.929 | 0.946 | |
Replicate 2 | 0.934 | 0.952 | 0.929 | |
Replicate 3 | 0.929 | 0.952 | 0.924 | |
Replicate 4 | 0.946 | 0.929 | 0.924 | |
Mean ± SD | 0.936 ± 0.011 |
For each CM preparation shown is the Pearson’s correlation coefficient (R2) of the pairwise analysis of log2 protein abundance (NSAF; the log-log plots are shown in Supplementary Figure S1).
RSV infection in BALB/c mice
BALB/c mice (Harlan) were inoculated intranasally (in) with 50 μL of pRSV (final inoculum, 107 pfu) diluted in PBS under light anesthesia as previously described (35). Twenty-four hours later, the animals were euthanized and their lungs fixed in paraformaldehyde for immunohistochemical analysis. Sections were prepared and stained with H&E or Periodic Acid Schiff (Abcam) stains using standard techniques.
Results
Analysis pipeline for cell type-specific differences in the epithelial secretome
In the first experiment, we examined the effects of RSV on secreted proteins in hBECs derived from the trachea vs hSAECs, derived from the terminal bronchioles. Because tert-immortalized cells maintain a highly differentiated epithelial phenotype over continuous passages, we used these cells for establishing and validating a secretome analysis pipeline. Tert-hBECs form pseudostratified ciliated monolayers on air-liquid interfaces (22). By contrast, tert-hSAECs express high amounts of p63 aldehyde dehydrogenase, and differ from tert-hBECs by their resistance to naphthalene injury, a characteristic of bronchiolar cells (36).
Our previous work has shown that RSV effectively replicates in both cell types, expressing cytokines, producing infectious virions and syncytia formation (37, 38). To directly compare the levels of RSV replication, tert-hBECs and tert-hSAECs were infected with sucrose cushion-purified (p)-RSV (MOI=1, 24 h). Cells were lysed and the expression of RSV nucleoprotein (N), matrix protein (M), phosphoprotein (P) and matrix M2-1 (M2-1) determined by LC-MS/MS (Fig. 1A). The levels of RSV expression for all proteins measured were dramatically elevated in tert-hBECs and tert-hSAECs relative to uninfected cells. Interestingly, RSV protein replication was 4-fold higher in tert-hBECs than in tert-hSAECs (Fig. 1A). Similar results were observed in the conditioned medium (CM) from each cell type (although the protein abundance was lower due to medium dilution), indicating viral secretion (Fig. 1B).
To determine the effects of RSV infection on cell viability, apoptosis and necrosis rates of control and RSV-infected tert-hBECs and tert-hSAECs (MOI=1, 24 h) were measured by flow cytometry. Cellular necrosis was minimal in both cell types in the absence or presence of RSV infection. However, in the absence of infection, tert-hBECs had a higher basal apoptotic rate than did tert-hSAECs (18.8% vs 10.8%, Fig. 1C). In both cell types, RSV infection reduced the apoptosis rate. The apoptotic rate of tert-hBECs fell from 18.8 to 12.5%, and of tert-hSAECs fell from 10.8% to 7.9% (Fig. 1C). These data are consistent with earlier studies demonstrating that cell death is not a major initial effect of RSV infection (39), and that the apoptosis rate is reduced upon RSV infection due to NFκB activation by the innate pathway, inducing anti-apoptotic genes (40). Together these data indicate that, under these conditions, the cells are viable, and actively replicating and secreting RSV.
We next sought to quantify the reproducibility of our label-free proteomics workflow to detect changes in secreted proteins by cell type and in response to RSV infection. Cell culture supernatants from 4 independent biological replicates from tert-hBECs vs tert-SAECs were analyzed in mock-infected cells and 24 h after RSV infection (Fig. 2A). 1,559 proteins were identified in the supernatants with a false discovery rate (FDR) of < 1%, determined by target-decoy database searching. To determine biological reproducibility, pairwise analysis of the log2-transformed protein abundance was performed. The Pearson correlations (r2) were > 0.85, indicating a high degree of concordance (Table I, Supplemental Fig. S1). We noted that across samples, the r2 was greater for the RSV-induced CM vs control (for control tert-hBECs, the groupwise mean r2 = 0.863 ± 0.008, whereas the RSV-infected tert-hBEC groupwise mean r2 = 0.957 ± 0.005; and for control tert-hSAECs, mean r2 = 0.863 ± 0.01 vs RSV-infected tert-hSAEC mean r2= 0.936 ± 0.011; both p<0.05 Student’s t-test). These data indicate that the method was reproducible, and that the highly abundant proteins in the RSV-induced CM were more accurately measured.
Secretome proteins are a distinct population of proteins from that produced by cellular lysis
To further extend our findings that the proteins in the secretome are not derived from cellular lysis, cellular lysates were prepared from the same experiment and analyzed in parallel (Fig 2A). 1,929 unique proteins were quantified from the tert-hBEC and tert-hSAEC whole-cell lysates (WCL). The global protein expression patterns in the CM and WCLs were first examined using principal component analysis (PCA). In this analysis, 91.6% of the variability was accounted for in the first two dimensions, indicating a robust analysis (Fig. 2B). The WCLs from control or RSV-infected cells clustered by cell type and presence of RSV infection, indicating that biological replicates were consistent. We noted that the control tert-hBEC WCL formed a distinct cluster from that of the tert-hSAEC WCLs, separated by the second principal component dimension (Fig. 2B). The RSV-infected tert-hBEC WCLs moved in the second dimension to form a cluster that overlapped with both control and RSV-infected tert-hSAEC WCLs. Both the control secretomes of tert-hBECs and tert-hSAECs clustered together, widely separated in the first dimension from the WCL clusters. Upon RSV infection, both the tert-hBEC and tert-hSAEC secretomes migrated up in the second dimension and down in the first dimension (Fig. 2B). Together, these analyses indicate that the secretome represented a distinct protein set from the cellular lysate, and that RSV induced significant changes in its composition.
A Venn diagram comparison of the WCL vs the secretome is shown in Fig. 2C; 460 proteins were present only in the secretome, 885 proteins were unique to the cellular proteome, and 1,044 proteins were present in both datasets. To further confirm that these protein sets were distinct, we conducted unbiased genome ontology cellular component (GOCC) enrichment analysis of the proteins present only in the CM dataset. This analysis indicated that the secretome was enriched with proteins derived from the extracellular region part (205 out of 460 proteins), while the cytoplasmic and mitochondrial proteins were depleted (Fisher Exact test, Benjamini-Hochberg FDR 0.1%; data not shown). By contrast, proteins unique to the WCL were enriched with mitochondrial, ribosomal, and nuclear proteins, and proteins in the extracellular region were depleted.
To confirm that the secreted proteins were independent of cellular lysis in a more quantitative manner, we used the normalized spectral abundance factor (NSAF) method to confirm the enrichment of the proteins in CM and WCL. NSAF is a widely used spectral counting method for label-free proteomic quantitation (41–43). In spectral counting, larger proteins usually generate more peptides and therefore more spectral counts than smaller proteins. Therefore, the number of spectral counts for each protein is first divided by the protein length, which defines the spectral abundance factor (SAF). Furthermore, to accurately account for sample-to- sample variation, individual SAF values are normalized by dividing by the sum of all SAFs for proteins identified in the sample, resulting in the NSAF value (31). In this manner, NSAF values are standardized across distinct samples, allowing direct comparisons of the relative protein abundance across samples.
We then conducted a pairwise comparison of NSAF values of proteins in the RSV CM to that of the WCL in RSV-infected tert-hBECs (Fig. 2D). A two-sample t-test was used to assess the statistical significance of protein enrichment in the RSV CM to that of the WCL. For tert-hBECs, proteins enriched in the CM (indicated in red, Benjamini-Hochberg FDR 1%) included macrophage inhibitory factor (MIF-1), macrophage migration CXCL-10, interferon-stimulated gene-15, high mobility group box (HMGB) 1/2, interferon-induced protein with tetratricopeptide repeats (IFIT)-3, IFN lambda 2, and others. All of these proteins are well-characterized, secreted proteins with defined roles in innate immunity. The abundance of these proteins was depleted in the WCLs. Conversely, we identified high-abundance intracellular proteins in the cell extract (indicated in blue, Benjamini-Hochberg FDR 1%) that were depleted in the CM, including histones H2HAC/1H2BM, mitochondrial single-stranded DNA-binding protein (SSBP)-1, heat shock 10kDa protein 1 (HSPE1), and actin gamma (ACTG)-1 (Fig. 2D).
Similar observations were made in the comparison of high-abundance proteins in the tert-hSAEC CM and WCLs (Fig. 2E). Although the proteins comprising the tert-hBEC and tert-hSAEC CM were similar, we noted that CCL5 was in high abundance in the tert-hBEC and much lower in the tert-hSAEC CM. Conversely, CCL20 and IL-6 were much more highly abundant in the tert-hSAEC secretome than in the tert-hBEC secretome (c.f. Figs. 2D, E). Together these data indicate that the CM samples represent a distinct proteome profile vs that in the WCL. We will refer to this population of proteins as the “secretome” in the remainder of this study.
Biological functions of the RSV-induced secretome
To further support the conclusion that the secretome and cell lysates represent distinct protein pools, we conducted unbiased genome ontology cellular component (GOCC) enrichment. The top-ranked cellular components for the RSV-induced secretome of tert-hBECs (indicated in red) were “extracellular matrix,” “extracellular space” and “extracellular organelle,” indicating that this sample was enriched in extracellular proteins relative to the reference human proteome (Fig. 2F). The cellular components corresponding to “cell part,” “macromolecular complexes,” and “ribonucleoprotein complexes” were depleted in the secretome (indicated in blue, Fig. 2F). By contrast, in the tert-hBEC WCLs, the GOCCs “nucleolar ribonucleoprotein complex,” “NADH dehydrogenase complex,” and “ribosomal complex” were the top-ranked components (red bars, Fig. 2F). Similarly, the “proteinaceous extracellular matrix” and “extracellular matrix” were the two most significantly depleted cellular components (blue bars, Fig. 2F). These data further support that the proteins identified in the secretome represent a distinct population from the intracellular proteome in the WCL. There were similar findings for tert-hSAECs, with extracellular proteins being the most highly enriched proteins in the hSAEC secretome GOCC analysis (Fig. 2G). We noted that the cellular component terms for the hBEC and hSAEC secretomes were almost identical (c.f. Figs 2F, G).
RSV induces exosome production in a cell type-dependent pattern
We noted that the majority of 1,044 proteins that were present in both the tert-hBEC and tert-hSAEC secretomes were cytosolic proteins. These cytosolic proteins may be secreted via unconventional protein secretory pathways, perhaps mediated by Golgi or endosomal export mechanisms (44). To this point, we found that 65 of these common proteins, including heat shock cognate 71 kDa protein (HSPA8), glyceraldehyde-3-phosphate GAPDH), and annexin A2 (ANXA2) (33) are prominent exosomal proteins. To provide some insight into whether endosomal transport was contributing to the RSV-induced secretome, we isolated and quantified exosomal proteins from control and RSV-infected tert-hBECs and tert-hSAECs.
Ultracentrifuge-purified exosomes manifested 112.8 ± 2.0 nm in size by dynamic light scattering, and exhibited a characteristic membrane composition in TEM (Fig. 3A). From this fraction, 937 exosomal proteins were identified; of these, 564 proteins were identified in the secretome (Fig. 3B; the 373 proteins unique to the exosomal fraction were below the limit of detection and not observed in the secretome analysis). The 937 proteins were subjected to GOCC. Significantly enriched cellular components included lysosomal, vacuolar, and endoplasmic reticular (Fig. 3C). Out of 937 identified exosome proteins, 853 were quantified across the experimental groups. Pairwise comparison by cell type and presence of RSV infection was accomplished using Student’s t-test, as shown in a Volcano plot, where the Log2 fold change is plotted vs the Log10-transformed p value (Fig. 3D). RSV infection caused up-regulation of 220 tert-hSAEC and 241 tert-hBEC exosomal proteins; and downregulation of 146 tert-hSAEC and 223 tert-hBEC exosomal proteins (FDR<0.05). The protein contents in the exosome also display cell type differences. In the basal state, 31 proteins were more abundant in the tert-hSAEC exosome fraction, while 60 proteins were more abundant in the tert-hBEC exosome fraction (FDR<0.05). After RSV infection, 273 exosome proteins were different by cell type, with 134 proteins more abundant in RSV-infected tert-hSAEC exosomes and 139 proteins more abundant in RSV-infected tert-hBEC exosomes (FDR<0.05).
We applied a statistical filter using a p value (Student’s t-test with Benjamini-Hochberg FDR correction of <0.05) and an expression filter of ± 5-fold change between control vs RSV-infected NSAF to identify the most highly differentially expressed exosomal proteins. The expression patterns were next compared by hierarchical clustering (Fig. 3E). These data clearly indicate that the exosomal proteins are different by cell type, and modified by the presence of RSV infection.
Of the 559 proteins in the secretome not directly found in the exosomal fraction, 80 proteins have identifiable signal peptides, with the remainder being enriched in lysosomal and vacuolar proteins. These findings suggest that the RSV-induced epithelial secretome is mediated primarily by exosomal protein release, with a smaller fraction due to lysosome- or vacuole-mediated export, and a small fraction by classical protein secretion.
Differential expression patterns by cell type
We next examined the differential expression patterns of secretome by cell type. Statistical analysis of microarray (SAM) was applied to identify differentially expressed proteins using 1% false discovery rate (FDR). SAM identified 71 proteins distinct in the control secretomes from tert-hBECs vs tert-hSAECs (Fig. 4A). Of these, 61 were upregulated in the tert-hSAEC secretome. Similarly, 131 proteins showed differential expression in the RSV-induced secretomes from tert-hBECs and tert-hSAECS (Fig. 4B). Of these, 65 were upregulated in hSAECs.
The differentially expressed proteins were subjected to 2-dimensional hierarchical clustering. Hierarchical clustering groups proteins (rows) whose expression patterns are most similar across cell type and treatment condition. The samples (columns) are also clustered by the patterns of proteins. In this analysis, the treatment groups co-clustered in the vertical dimension, consistent with the findings in PCA analysis that the replicates from each cell type are highly similar (Fig. 4C). By inspection of the proteins in the rows, 5 distinct patterns of protein expression emerged. Cluster 1 represents proteins abundant in control tert-hBECs whose expression is inhibited in response to RSV (not expressed by tert-hSAECs). Cluster 2 represents proteins expressed by tert-hSAECs whose abundance is decreased in response to RSV. Cluster 3 contains proteins only expressed by RSV-infected tert-hSAECs. Cluster 4 contains proteins induced by RSV that are common to both cell types. Cluster 5 contains proteins induced by tert-hBECs but not tert-hSAECs. We note that cluster 3 contains a number of immunologically significant proteins, including CXCL1, IL-6 and CCL20. These data suggest that RSV induces cell-type differences in the secretion of immunologically significant cytokines. Collectively, our analysis pipeline developed using tert-immortalized human epithelial cells, enables the reliable analysis of epithelial secretomes to understand differences by cell type and RSV-induced expression patterns.
Primary epithelial cell secretomes
We next applied our analysis pipeline to primary isolates of human BECs (phBECs) and primary isolates of SAECs (phSAECs). To control for donor effects, the analysis was conducted on three independent donors (donor demographic data are shown in Supplemental Table I); two biological replicates were analyzed for each. As validation of the distinct phenotypes, immunofluorescence microscopy was conducted to examine differences in epithelial cytokeratin expression. phBECs express cytokeratins 7 and 19; by contrast, hSAECs have low (or undetectable) cytokeratin 7 and strong cytokeratin 19 expression (Fig. 5A). Both cell types support active RSV replication and secretion of virus (not shown).
Secretome fractions were prepared from control and RSV-infected primary cells. We identified 2,376 proteins with FDR 1%. SAM analysis identified 577 proteins in the secretome from control (uninfected) cells whose expression varied by cell type, and 966 proteins in the secretome from RSV-infected cells whose expression varied by cell type (FDR of 1%). To focus on the most robust differentially expressed proteins, we filtered proteins that showed a 5-fold expression change or greater; this resulted in 492 of the most highly significant and induced proteins. This filtered dataset was subjected to 2-dimensional hierarchical clustering, where each column represents a sample and each row represents an individual protein’s abundance. We observed that each sample co-clustered with its replicate, as well as by being grouped by cell type and RSV treatment (Fig. 5B). The row-wise clustering of proteins produced a pattern highly similar to that observed in the Tert-immortalized hBECs and hSAECs (c.f. Figs 5B and 4C); in this example, cluster 2 represents 11 proteins upregulated by RSV infection in phBECs; cluster 3 represents 116 proteins upregulated by RSV infection in phSAECs; and cluster 4 contains 203 proteins induced by both cell types (Table II).
Table II.
Cls | ID | Name | Cls | ID | Name | Cls | ID | Name | Cls | ID | Name | Cls | ID | Name | Cls | ID | Name |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Q96JP9 | CDHR1 | 3 | P30519 | HMOX2 | 4 | P52823 | STC1 | 4 | Q9UKK9 | NUDT5 | 4 | P55884 | EIF3B | 5 | Q8WVN6 | SECTM1 |
1 | Q29960 | HLA-C | 3 | Q9P0L0 | VAPA | 4 | Q99941 | ATF6B | 4 | O15511 | ARPC5 | 4 | P26599 | PTBP1 | 5 | O43240 | KLK10 |
1 | P09871 | C1S | 3 | P21399 | ACO1 | 4 | P06576 | ATP5B | 4 | O95373 | IPO7 | 4 | P06748 | NPM1 | 5 | P06731 | CEACAM5 |
1 | O14817 | TSPAN4 | 3 | P09417 | QDPR | 4 | O00754 | MAN2B1 | 4 | Q15366 | PCBP2 | 4 | O14980 | XPO1 | 5 | Q9Y337 | KLK5 |
1 | P41159 | LEP | 3 | P23434 | GCSH | 4 | P04080 | CSTB | 4 | P53582 | METAP1 | 4 | O43776 | NARS | 5 | P15941 | MUC1 |
1 | Q9P121 | NTM;OPCML | 3 | P35270 | SPR | 4 | P18510 | IL1RN | 4 | Q13247 | SRSF6 | 4 | Q9UBQ5 | EIF3K | 5 | Q05639 | EEF1A2 |
1 | Q8IUX7 | AEBP1 | 3 | Q92882 | OSTF1 | 4 | P20062 | TCN2 | 4 | Q13177 | PAK2 | 4 | P62318 | SNRPD3 | 5 | Q92876 | KLK6 |
1 | P01011 | SERPINA3 | 3 | O15347 | HMGB3 | 4 | P51610 | HCFC1 | 4 | Q14240 | EIF4A2 | 4 | Q16555 | DPYSL2 | 5 | Q96NY8 | PVRL4 |
1 | P20908 | COL5A1 | 3 | Q99798 | ACO2 | 4 | P16403 | HIST1H1C | 4 | Q9BW04 | SARG | 4 | P05388 | RPLP0 | 5 | Q9GZN4 | PRSS22 |
1 | P16189 | HLA-A | 3 | Q9Y2D5 | AKAP2 | 4 | P62854 | RPS26/11 | 4 | Q9P1F3 | ABRACL | 4 | Q16531 | DDB1 | 5 | B0FP48 | UPK3BL |
1 | Q7Z406 | MYH14 | 3 | P58107 | EPPK1 | 4 | Q15181 | PPA1 | 4 | P49720 | PSMB3 | 4 | Q13263 | TRIM28 | 5 | Q99988 | GDF15 |
1 | O75487 | GPC4 | 3 | Q9NX46 | ADPRHL2 | 4 | P12004 | PCNA | 4 | P55735 | SEC13 | 4 | Q03405 | PLAUR | 5 | O00220 | TNFRSF10A |
1 | P08254 | MMP3 | 3 | P04181 | OAT | 4 | P20340 | RAB6A/B | 4 | P84090 | ERH | 4 | Q09028 | RBBP4 | 5 | Q6UXB2 | CXCL17 |
1 | P01344 | IGF2 | 3 | P50452 | SERPINB8 | 4 | Q15819 | UBE2V2 | 4 | P30419 | NMT1 | 4 | Q07955 | SRSF1 | 5 | P30455 | HLA-A |
1 | Q9BY76 | ANGPTL4 | 3 | Q96EK6 | GNPNAT1 | 4 | P06454 | PTMA | 4 | P14550 | AKR1A1 | 4 | P31943 | HNRNPH1 | 5 | Q14210 | LY6D |
1 | O00469 | PLOD2 | 3 | Q969D9 | TSLP | 4 | P51148 | RAB5C | 4 | Q96KP4 | CNDP2 | 4 | O00231 | PSMD11 | 5 | P02533 | KRT14 |
1 | Q14766 | LTBP1 | 3 | Q8TEA8 | DTD1 | 4 | P46060 | RANGAP1 | 4 | P10809 | HSPD1 | 4 | P23588 | EIF4B | 5 | Q14956 | GPNMB |
1 | P26022 | PTX3 | 3 | Q5JRX3 | PITRM1 | 4 | Q13838 | DDX39A/B | 4 | P84077 | ARF1 | 4 | P08621 | SNRNP70 | 5 | Q08431 | MFGE8 |
1 | P35442 | THBS2 | 3 | Q53FA7 | TP53I3 | 4 | P29966 | MARCKS | 4 | P47895 | ALDH1A3 | 4 | Q9HB71 | CACYBP | 5 | O75144 | ICOSLG |
1 | P05090 | APOD | 3 | P54105 | CLNS1A | 4 | P54727 | RAD23B | 4 | Q15056 | EIF4H | 4 | P05023 | ATP1A1 | 5 | Q13510 | ASAH1 |
1 | P35573 | AGL | 3 | O75884 | RBBP9 | 4 | O15144 | ARPC2 | 4 | Q9UL46 | PSME2 | 4 | P62195 | PSMC5 | 5 | Q13421 | MSLN |
1 | P01009 | SERPINA1 | 3 | O95994 | AGR2 | 4 | P31153 | MAT2A | 4 | Q15121 | PEA15 | 4 | O75821 | EIF3G | 5 | Q86XX4 | FRAS1 |
1 | P02751 | FN1 | 3 | Q8NBJ7 | SUMF2 | 4 | Q12765 | SCRN1 | 4 | P53004 | BLVRA | 4 | P38159 | RBMX | 5 | P12273 | PIP |
1 | Q8NES3 | LFNG | 3 | P16619 | CCL3L1 | 4 | P55060 | CSE1L | 4 | O60271 | SPAG9 | 4 | Q99536 | VAT1 | 5 | P25391 | LAMA1 |
1 | P48307 | TFPI2 | 3 | P52566 | ARHGDIB | 4 | O95202 | LETM1 | 4 | P20290 | BTF3 | 4 | Q96AE4 | FUBP1 | 5 | Q6UVK1 | CSPG4 |
1 | Q00341 | HDLBP | 3 | O60749 | SNX2 | 4 | P29508 | SERPINB3 | 4 | P53999 | SUB1 | 4 | P61088 | UBE2N | 5 | Q6UWP8 | SBSN |
1 | P05231 | IL6 | 3 | P36551 | CPOX | 4 | Q16629 | SRSF7 | 4 | O43396 | TXNL1 | 4 | Q9NTK5 | OLA1 | 5 | O15031 | PLXNB2 |
1 | P09238 | MMP10 | 3 | Q9UFN0 | NIPSNAP3A | 4 | P38606 | ATP6V1A | 4 | Q9UHD1 | CHORDC1 | 4 | P40926 | MDH2 | 5 | Q13361 | MFAP5 |
1 | P32004 | L1CAM | 3 | Q8WWM9 | CYGB | 4 | Q13451 | FKBP5 | 4 | Q07666 | KHDRBS1 | 4 | P30048 | PRDX3 | 5 | P61812 | TGFB2 |
1 | Q96AY3 | FKBP10 | 3 | P04179 | SOD2 | 4 | P62263 | RPS14 | 4 | P35998 | PSMC2 | 4 | P35221 | CTNNA1 | 5 | Q09328 | MGAT5 |
1 | P30042 | C21orf33 | 3 | P67870 | CSNK2B | 4 | Q15942 | ZYX | 4 | Q01650 | SLC7A5 | 4 | P49419 | ALDH7A1 | 5 | P13929 | ENO3 |
1 | P63136 | ERVK-6/18/19/25 | 3 | O60701 | UGDH | 4 | P20073 | ANXA7 | 4 | Q13185 | CBX3 | 4 | P48739 | PITPNB | 5 | P98095 | FBLN2 |
1 | Q9UK41 | VPS28 | 3 | P30084 | ECHS1 | 4 | Q01581 | HMGCS1 | 4 | O60218 | AKR1B10 | 4 | Q9NR45 | NANS | 5 | Q68BL7 | OLFML2A |
3 | P13804 | ETFA | 4 | Q92688 | ANP32B | 4 | P21281 | ATP6V1B2 | 4 | Q9Y3A5 | SBDS | 5 | P16870 | CPE | |||
2 | Q9UMF0 | ICAM5 | 3 | O15305 | PMM2 | 4 | Q06323 | PSME1 | 4 | Q16222 | UAP1 | 5 | Q99523 | SORT1 | 5 | P13686 | ACP5 |
2 | O14792 | HS3ST1 | 3 | O76054 | SEC14L2 | 4 | P12956 | XRCC6 | 4 | P51149 | RAB7A | 5 | Q6UW49 | SPESP1 | 5 | Q9UI42 | CPA4 |
2 | Q01638 | IL1RL1 | 3 | P49411 | TUFM | 4 | Q02790 | FKBP4 | 4 | O43765 | SGTA | 5 | O75367 | H2AFY | 5 | P12109 | COL6A1 |
2 | Q29980 | MICB | 3 | Q5T2P8 | ANXA8L1 | 4 | Q13404 | UBE2V1 | 4 | P62266 | RPS23 | 5 | Q5D862 | FLG2 | 5 | O75976 | CPD |
2 | P30499 | HLA-C | 3 | Q16836 | HADH | 4 | P63208 | SKP1 | 4 | P17980 | PSMC3 | 5 | O60353 | FZD6 | 5 | P07225 | PROS1 |
2 | P05204 | HMGN2/3 | 3 | Q9Y4K1 | AIM1 | 4 | Q13765 | NACA | 4 | Q9UK22 | FBXO2 | 5 | A1L020 | MEX3A | 5 | P09668 | CTSH |
2 | P17693 | HLA-G | 3 | Q9HD15 | SRA1 | 4 | P36871 | PGM1 | 4 | P12268 | IMPDH2 | 5 | P03952 | KLKB1 | 5 | P16035 | TIMP2 |
2 | Q9NQC3 | RTN4 | 3 | Q59GN2 | RPL39P5 | 4 | P28070 | PSMB4 | 4 | Q14203 | DCTN1 | 5 | Q9GZM5 | YIPF3 | 5 | Q9NPC4 | A4GALT |
2 | Q96QD8 | SLC38A2 | 3 | O15400 | STX7 | 4 | Q5VT79 | ANXA8L2 | 4 | P61019 | RAB2A;RAB2B | 5 | Q9NPH3 | IL1RAP | 5 | P23471 | PTPRZ1 |
2 | P12643 | BMP2 | 3 | P31146 | CORO1A | 4 | P10314 | HLA-A | 4 | Q99733 | NAP1L4 | 5 | Q8NCC3 | PLA2G15 | 5 | Q9UIV8 | SERPINB13 |
2 | P25205 | MCM3 | 3 | Q13642 | FHL1 | 4 | O95571 | ETHE1 | 4 | Q7L576;Q96F07 | CYFIP1;CYFIP2 | 5 | Q9BZG9 | LYNX1 | 5 | Q641Q3 | METRNL |
3 | Q9H993 | C6orf211 | 4 | P05091 | ALDH2 | 4 | O14818 | PSMA7 | 5 | Q86YZ3 | HRNR | 5 | P0DJI9 | SAA2 | |||
3 | Q13509 | TUBB3 | 3 | Q15149 | PLEC | 4 | Q5TZA2 | CROCC | 4 | P41227 | NAA10 | 5 | O00748 | CES2 | 5 | Q5SYB0 | FRMPD1 |
3 | Q9Y570 | PPME1 | 3 | P35754 | GLRX | 4 | P38571 | LIPA | 4 | P07910 | HNRNPC | 5 | P24593 | IGFBP5 | 5 | Q08174 | PCDH1 |
3 | P07738 | BPGM | 3 | Q01995 | TAGLN | 4 | O14745 | SLC9A3R1 | 4 | Q9UMX0 | UBQLN1 | 5 | Q9Y653 | GPR56 | 5 | P32926 | DSG3 |
3 | P61081 | UBE2M | 3 | P48745 | NOV | 4 | P63098 | PPP3R1 | 4 | P49588 | AARS | 5 | Q92997 | DVL3 | 5 | P03973 | SLPI |
3 | P56211 | ARPP19 | 3 | O00244 | ATOX1 | 4 | Q9H0E2 | TOLLIP | 4 | P62277 | RPS13 | 5 | O95428 | PAPLN | 5 | Q6E0U4 | DMKN |
3 | Q9BV57 | ADI1 | 3 | P26885 | FKBP2 | 4 | P49721 | PSMB2 | 4 | P63167 | DYNLL1 | 5 | P52798 | EFNA4 | 5 | O75635 | SERPINB7 |
3 | Q9H8S9 | MOB1A/B | 3 | P06132 | UROD | 4 | P17066 | HSPA6 | 4 | Q04637 | EIF4G1 | 5 | P25774 | CTSS | 5 | Q9Y5Y6 | ST14 |
3 | P50583 | NUDT2 | 3 | P37268 | FDFT1 | 4 | P25789 | PSMA4 | 4 | P67809 | YBX1 | 5 | Q6PCB0 | VWA1 | 5 | O95274 | LYPD3 |
3 | P99999 | CYCS | 3 | Q08257 | CRYZ | 4 | O76003 | GLRX3 | 4 | O60763 | USO1 | 5 | O75054 | IGSF3 | 5 | Q99519 | NEU1 |
3 | P42126 | ECI1 | 3 | Q8NFU3 | TSTD1 | 4 | P00918 | CA2 | 4 | P52895 | AKR1C2 | 5 | P21217 | FUT3 | 5 | Q16610 | ECM1 |
3 | Q9P2F8 | SIPA1L2 | 3 | Q9NQR4 | NIT2 | 4 | Q01130 | SRSF2 | 4 | P52788 | SMS | 5 | P20800 | EDN2 | 5 | P07339 | CTSD |
3 | A6NDG6 | PGP | 3 | P30838 | ALDH3A1 | 4 | P15924 | DSP | 4 | P05198 | EIF2S1 | 5 | Q9NY97 | B3GNT2 | 5 | P80188 | LCN2 |
3 | Q1KMD3 | HNRNPUL2 | 3 | P78556 | CCL20 | 4 | P30740 | SERPINB1 | 4 | P43686 | PSMC4 | 5 | Q9BUD6 | SPON2 | 5 | Q9NQ38 | SPINK5 |
3 | Q86TI2 | DPP9 | 3 | O95394 | PGM3 | 4 | Q16831 | UPP1 | 4 | Q99729 | HNRNPAB | 5 | P29373 | CRABP2 | 5 | P49862 | KLK7 |
3 | P25325 | MPST | 3 | Q9ULC4 | MCTS1 | 4 | P46783 | RPS10 | 4 | Q7L1Q6 | BZW1 | 5 | P00352 | ALDH1A1 | 5 | Q9UBC9 | SPRR3 |
3 | O43813 | LANCL1 | 3 | P12532 | CKMT1A | 4 | P52597 | HNRNPF | 4 | Q15370 | TCEB2 | 5 | P22528 | SPRR1B | 5 | A8K2U0 | A2ML1 |
3 | P40261 | NNMT | 3 | Q6FI81 | CIAPIN1 | 4 | Q96S86 | HAPLN3 | 4 | Q9Y617 | PSAT1 | 5 | P54652 | HSPA2 | 5 | P06396 | GSN |
3 | Q00169 | PITPNA | 3 | P42330 | AKR1C3 | 4 | P50995 | ANXA11 | 4 | Q99873 | PRMT1 | 5 | P42785 | PRCP | 5 | Q9UMX5 | NENF |
3 | P61086 | UBE2K | 3 | Q13011 | ECH1 | 4 | Q15847 | ADIRF | 4 | P22626 | HNRNPA2B1 | 5 | P10619 | CTSA | 5 | P17096 | HMGA1 |
3 | Q13126 | MTAP | 3 | P51572 | BCAP31 | 4 | P08133 | ANXA6 | 4 | P11940 | PABPC1 | 5 | Q14563 | SEMA3A | 5 | Q9NZ08 | ERAP1 |
3 | P10768 | ESD | 3 | O75390 | CS | 4 | P48163 | ME1 | 4 | O75223 | GGCT | 5 | O95490 | LPHN2 | |||
3 | P50479 | PDLIM4 | 3 | P30520 | ADSS | 4 | P07384 | CAPN1 | 4 | Q92841 | DDX17 | 5 | Q00888 | PSG4 | |||
3 | P82979 | SARNP | 3 | Q9NQ88 | TIGAR | 4 | P35222 | CTNNB1 | 4 | Q92499 | DDX1 | 5 | Q9HB40 | SCPEP1 | |||
3 | P27144 | AK4 | 3 | Q9H2U2 | PPA2 | 4 | P27695 | APEX1 | 4 | P31939 | ATIC | 5 | Q07954 | LRP1 | |||
3 | Q9BY32 | ITPA | 3 | Q15833 | STXBP2 | 4 | Q9H3K6 | BOLA2 | 4 | P38646 | HSPA9 | 5 | Q99102 | MUC4 | |||
3 | P48637 | GSS | 3 | P21266 | GSTM3 | 4 | P07203 | GPX1 | 4 | Q9H6S3 | EPS8L2 | 5 | Q9UN76 | SLC6A14 | |||
3 | Q9GZP4 | PITHD1 | 3 | O75368 | SH3BGRL | 4 | O95777 | LSM8 | 4 | P15170 | GSPT1 | 5 | P60022 | DEFB1 | |||
3 | Q9NZD2 | GLTP | 3 | P43490 | NAMPT | 4 | Q9BVG4 | PBDC1 | 4 | P62269 | RPS18 | 5 | O00115 | DNASE2 | |||
3 | Q05397 | PTK2 | 3 | Q8WUP2 | FBLIM1 | 4 | P14923 | JUP | 4 | 5 | Q99715 | COL12A1 | |||||
3 | P52943 | CRIP2 | 3 | P19623 | SRM | 4 | P22102 | GART | 4 | Q96QK1 | VPS35 | 5 | P16278 | GLB1 | |||
3 | P42771 | CDKN2A | 3 | Q9HAV7 | GRPEL1 | 4 | P05455 | SSB | 4 | Q15019 | SEPTIN2 | 5 | O60259 | KLK8 | |||
3 | P29218 | IMPA1 | 4 | P00568 | AK1 | 4 | O75436 | VPS26A | 5 | P58062 | SPINK7 | ||||||
3 | P34897 | SHMT2 | 4 | P35080 | PFN2 | 4 | P14866 | HNRNPL | 5 | P15586 | GNS | ||||||
3 | Q9BSJ8 | ESYT1 | 4 | Q8WUW1 | BRK1 | 4 | Q92973 | TNPO1 | 5 | P20061 | TCN1 | ||||||
3 | P23368 | ME2 | 4 | Q9Y383 | LUC7L2 | 4 | Q14152 | EIF3A | 5 | Q9UBX7 | KLK11 | ||||||
3 | P42704 | LRPPRC | 4 | P30044 | PRDX5 | 4 | Q13442 | PDAP1 | 5 | Q14CN2 | CLCA4 | ||||||
3 | O15231 | ZNF185 | 4 | Q13151 | HNRNPA0 | 5 | Q9H7M9 | C10orf54 | |||||||||
3 | Q13630 | TSTA3 | 4 | P62495 | ETF1 | 5 | P01833 | PIGR | |||||||||
3 | O00515 | LAD1 | 5 | P36543 | ATP6V1E1 | ||||||||||||
5 | Q9Y2A9 | B3GNT3 | |||||||||||||||
5 | Q8WXI7 | MUC16 | |||||||||||||||
5 | O43653 | PSCA | |||||||||||||||
5 | Q14508 | WFDC2 |
For each cluster (Cls) shown in Fig. are listed the protein ID and name.
Independent confirmation of differential secretion patterns
To validate the differentially expressed protein patterns, we independently quantified their expression using SID-SRM-MS. This method is a ‘targeted’ MS approach for the detection and accurate quantification of proteins in a complex background where signature proteotypic peptides unique to the protein of interest are monitored in a high mass accuracy mass spectrometer (34, 45–47). Because the peptide fragments are then subjected to fragmentation, the assay provides structural specificity and therefore is the most accurate approach available for direct quantification of target proteins in a complex mixture (47). SRM assays were developed for the measurement of 15 proteins. These assays confirmed the constitutive cell type-specific expression of fibronectin (FN1), and the RSV-induced expression of guanine nucleotide-binding protein (GNAL2), annexin (ANA)-X2, ras oncogene (RAB)-7A, aldolase (ALDO)-A, heat shock protein (HSP)-90, vimentin (VIM), IL-6, integrin alpha 3 (ITGA3), caveolin (CAV)-1 and IFIT-1/2/3 by phSAECs (Fig. 6). These data indicated that RSV induces differential expression of proteins by cell type.
Biological Functions of Secreted Proteins
To gain further understanding of RSV-inducible proteins, we analyzed the clusters by GO biological function and Gene Set Enrichment Analysis (GSEA), primarily focusing on clusters 2, 3 and 4 (shown in Fig. 5B). The 11 proteins in cluster 2 were too limited to identify extensive enriched GO categories. Relative to the human proteome, cluster 2 was depleted in the GO category for metabolic process (Fig. 7A). GSEA showed enrichment for extrinsic prothrombin pathway and fibrinolysis pathway, predominantly determined by the presence of fibrinogen (Fig. 7A). The 116 proteins in cluster 3, uniquely expressed by RSV-infected hSAECs, showed enrichment for metabolic processes (organic acid, cellular ketone, and small molecule) relative to the human proteome, and depletion in RNA processing (Fig. 7B). GSEA identified enrichment of canonical pathways for glycoxylate, carbonyl, porphyrin and amino acid metabolism, and oxidative reduction (Fig. 7B). This analysis suggests that phSAECs secrete proteins controlling nucleotide-sugar bioenergetic processes in response to RSV.
The 203 proteins secreted by both epithelial cell types (cluster 4, Fig. 5B) were analyzed in the same manner. This analysis identified the most GO functions numerically, many of which could be collapsed into mRNA processing (splicing, catabolism, ribonuclease complex assembly), DNA cell cycle regulation and others (Fig. 7C). GSEA indicated enrichment in mRNA destabilization, Wnt signaling, HIV factor interactions and mRNA interaction/metabolism (Fig. 7C).
Upstream factor analysis of proteins unique to hSAECs
To obtain further insights into the differentially regulated proteins, we subjected all proteins showing differential expression to IPA upstream regulator analysis (48). Upstream regulator analysis compares the known effect (transcriptional activation or repression) of a transcriptional regulator on its target genes to the observed changes in protein abundance. In phBECs, the epithelium-specific ets homologous factor (EHF) was predicted to be more upregulated and responsible for regulating MUC1, serum amyloid A2 and kallikrein-related peptidase (KLK-6/7) (Fig. 8, left panel). In phSAECs, the NFκB transcription factor was predicted to be activated to a greater degree in response to RSV infection than in hBECs. The NFκB network is responsible for regulating TSLP, CCL20, BMP2, MMP3 and SOD2 (Fig. 8, right panel).
Secretion of Th2-differentiating and mucin-inducing cytokines
Our protein-level analysis of the proteins unique to hSAECs (cluster 3, Fig. 5B) identified three proteins highly relevant to the pathogenesis of RSV LRTI – TSLP, CCL20, and CCL3-L1. These proteins contain signal peptide sequences and are found in the free (non-exosomal fraction). TSLP is produced by RSV-infected airway epithelium and promotes Th2 differentiation by inducing the maturation of antigen-presenting dendritic cells (49, 50). CCL20 is a potent inducer of epithelial mucin production (51), Th17 lymphocyte and dendritic cell chemotaxis that promotes formation of mucosal lymphoid tissue formation and plays an important role in the pathology of RSV-induced lung inflammation (52). Chemokine (C-C motif) ligand 3-like 1 (CCL3-L1) is chemotactic for monocytes and lymphocytes, and interacts with CCR5, a receptor linked to RSV LRTI (53).
We therefore selected these three immunologically important proteins previously implicated in the pathogenesis of RSV LRTI for validation experiments. To independently measure their differential expression by RSV infection and cell type, we developed and applied highly specific SID-SRM-MS assays to measure target protein abundance in the phBEC and phSAEC secretomes in the presence or absence of RSV infection. We were able to detect a 10-fold increase in CCL20, TSLP and CCL3-L1 expression in RSV-infected phSAECs relative to uninfected controls (Fig. 9A). By contrast, RSV-infected phBECs showed only 2-fold induction of each chemokine, and at much lower amounts than that in phSAECs (Fig. 9A). As shown in Fig. 9B, the presence or absence of the BSA/growth factor supplements in the cell culture medium did not affect the RSV-induced cell-type differences in the secretion of CCL20, TSLP and IL-6.
phSAEC-secreted CCL20 is a biologically active mucin inducer
Although mucins constitute an important arm of the innate immune response via their ability to trap microorganisms (54), mucins also play an important role in the pathogenesis of airway obstruction in RSV LRTI. As described earlier, mucous plugging of the small airways is an important mechanism for atelectasis in bronchiolitis, producing ventilation-perfusion mismatching and hypoxia (55, 56). To determine whether the RSV-induced CCL20 production was at levels sufficient for biological activity, we first evaluated whether phBECs express the CCR6 receptor CCR6 mRNA expression by Q-RT-PCR. Both cell types express CCR6 in uninfected and infected conditions (Fig. 9C). We next stimulated naïve phBECs with either recombinant CCL20 or CM from RSV-infected phSAECs and assayed for MUC5A mRNA expression by Q-RT-PCR. Recombinant CCL20 induced a reproducible 8-fold induction of MUC5AC mRNA expression relative to control, which was lost at higher concentrations (Fig. 9D). RSV-CM produced a similar 8-fold induction of MUC5A (Fig. 9E). Both of these activities were inhibited by the addition of neutralizing CCL20 Ab; pre-immune IgG had no effect (Fig. 9F, G). Together these data indicate that RSV-infected phSAECs produce biologically active CCL20 that stimulates mucin production.
Confirmation of enhanced CCL20 in lower airway epithelial cells in vivo
Our quantitative in vitro proteomic studies suggest that lower airway epithelial cells exhibit enhanced CCL20 secretion upon RSV infection. To confirm this, we examined CCL20 expression in a BALB/c mouse model of acute RSV infection established in our laboratories (57). Immunofluorescence (IF) assays were performed on proximal and distal airways in control and RSV-infected mice. In the absence of primary antibody, no fluorescence was observed (Fig. 10A). In proximal airways, IF was faintly distributed within the epithelial layer and weakly induced upon RSV infection (not shown). By contrast, CCL20 IF was strongly induced in the smaller airways, both upon RSV infection (Fig. 10A). These (< 1mm diameter) airways were lined with single layer of cuboidal epithelium and lacked cartilage representing bronchiolar and terminal bronchiolar structures (adjacent to alveoli).
To examine whether enhanced mucin production was seen in this model, tissue sections were stained with PAS to assess mucin production. We observed enhanced PAS staining in these smaller, distal airways (Fig. 10B). Together, these studies confirm that lower airway epithelial cells in the distal airways produce enhanced CCL20 expression with increased mucin production in this mouse model of RSV infection.
Discussion
RSV is an important human pathogen representing the most common cause of childhood LRTI (7) and the leading cause of infant viral death (9). RSV directly replicating in the airway epithelium triggers pulmonary innate immune response. RSV replication produces the viral molecular patterns 5′-phosphorylated RNA and dsRNA that are recognized by the cytoplasmic RIG-I cytoplasmic pattern recognition receptor, which induces NFκB and IRF3 translocation and activation; these inducible transcription factors coordinate the expression of inflammatory chemokines via extensive cross-talk pathways (58). Consequently, infected epithelial cells rapidly secrete type I and -III IFNs (24, 37, 59), and 17 C-, CXC- and CC-type chemokines (15, 60, 61). How RSV infection of the lower airway contributes to the observed pathophysiology is largely unknown. Previous limited work comparing ciliated and transformed type II-like alveolar cells have found that these different cell types exhibit qualitatively distinct patterns of RSV-induced CC chemokine production (20). In this study, we apply unbiased proteomics to identify 577 high- confidence proteins whose RSV-induced expression patterns differ between primary human epithelial cells derived from the conductive airway (trachea) and those of the small airways (bronchioles). A surprising finding was that about third of the proteins identified in the secretome are exosomal. Although a number of RSV-inducible proteins are common, RSV induces a group of proteins unique to the phSAECs that are immunologically significant – TSLP, CCL20, CCL3-L1 and IL-6. Differential expression of these proteins was independently validated by specific SID-SRM-MS assays. We demonstrate that CCL20 is the major mucin-promoting cytokine in hSAECs secretome, and validate its preferential expression in lower airways in a BALB/c mouse model of RSV infection. These data advance our understanding of the epithelial innate response and provide insight into how RSV LRTI is associated with enhanced mucin production and lower airway obstruction.
The epithelial surface of the pulmonary mucosa consists of highly differentiated, regionally distinct epithelial cell types, each playing a specialized role in normal pulmonary function and host defense. Upper airway ciliated epithelial cells produce protective epithelial lining fluid and regulate water and ion transport, whereas pseudostratified tracheal airway cells produce mucins and coordinated ciliary beating to facilitate mucociliary particulate clearance (62). Despite a significant amount of cellular proteomic profiling of RSV-epithelial interactions (63–65), a systematic understanding of the spectrum of secreted proteins as a function of epithelial phenotype has not been obtained. In this study, we have selected a model of primary human airway epithelial cells cultured in submerged monolayers. This cellular model has been extensively used for the study of innate responses to RSV and has provided important insights into the mechanisms of activation of the innate response and its subversion by RSV nonstructural proteins. Although growth under these conditions confer basal cell-like characteristics, recent studies have shown that basal cell infection is important for amplifying RSV infection in ciliated cells (66). Our validation of differential cytokine expression in the mouse model establishes further relevance of our findings to pulmonary host defense. An important extension of our work will be to conduct these studies in polarized cells in air-liquid interface.
Recent advances in secretome profiling have provided interesting insights into inducible protein secretion. Secretome profiling of macrophages using a proteomic pipeline similar to ours showed that TLR4 activation induced the production of over 775 proteins present in concentrations greater than 1 pg/ml (67). Like our study, the vast majority of secreted proteins that were identified included lysosomal, cytoplasmic and nuclear proteins – proteins that typically lack signal peptides. To minimize the possibility that these unconventionally secreted proteins represented cellular necrosis or apoptosis, we employed a lower MOI and sampled early time points, before significant apoptosis was produced in our experimental design. In fact, direct measurements of the apoptotic rate showed less apoptosis in RSV-infected than in control cells, due to the anti-apoptotic effects of NFκB demonstrated by earlier studies (40). Moreover, direct comparison of the secreted vs WCL proteomic profiles, functional classification by GO, and unbiased PCA clustering all consistently indicate that the CM and WCLs are drawn from distinct protein pools. Instead, we demonstrate here that a major fraction of secreted proteins from epithelial cells are contained within membrane-bound exosomes.
Exosomes are membrane-bound nanoparticles derived from intracellular multivesicular bodies that contain proteins and microRNAs important in intercellular communication (68). Studies on exosomes isolated from bronchoalveolar lavage samples of atopic asthmatics have shown that the exosomes may be involved in the regulation of bronchial hyperresponsiveness and inflammation (69, 70). Other studies have shown that exosomes isolated from highly differentiated ciliated tracheal epithelial cells mediate a protective antiviral response via the expression of sialoproteins that block influenza infection (71). Others have found that IL-13, a mediator of allergy and Th2 lymphocyte recruitment in asthma, induces exosome production in the airway that promotes the chemotaxis of macrophages (72). The role of exosomes in anti-RSV innate immunity and inflammation will require further exploration.
Additional proteins identified in the RSV secretome appear to be derived from unconventional protein secretory pathways. Our identification of lysosomal, vacuolar and nuclear proteins expressed in response to RSV replication suggests that unconventional protein secretion, perhaps through Golgi compartments, is also a component of the epithelial innate response.
Bioinformatic comparisons of the RSV-infected hBEC secretome vs the hSAEC secretome show that both cell types inducibly express over 200 common proteins. GO analysis indicate that these proteins play diverse functional roles. Although our focus is on proteins of potential immunological importance to LRTIs, these data may help to identify other potential mechanisms of pulmonary innate defense. We note, for example, the presence of multiple types of RNA-binding proteins of distinct functional classes; these may serve to protect the airway by binding or metabolizing infectious nucleic acids. Similarly, the identification of Wnt signaling, an important epithelial morphogenic pathway (73), may provide clues to mechanisms of airway remodeling induced by RSV infection.
RSV LRTIs have been associated with Th2 polarization and enhanced aeroallergen sensitivity (74, 75). The epithelium plays an important role in shaping the T cell lymphocytic response through the patterns of chemokines and cytokines produced during infection. TSLP is an RSV-inducible, epithelium-derived chemokine important in allergic and RSV-induced airway inflammation (76, 77) secreted by airway cells in an NFκB-dependent mechanism (49) consistent with our upstream factor analysis. Although TSLP has a broad variety of target cell responses, its ability to activate pDC populations and promote Th2 lymphocyte-predominant inflammation is especially relevant to the pathophysiology of severe LRTI infection. Similarly, CCL20 is important in pDC activation and the recruitment of Th17 lymphocytes to sites of inflammation (78). The actions of Th17 cells have been also implicated in the pathogenesis of RSV LRTI (79), where clinical studies in children with severe RSV infection showed increased IL-17 levels in their airway fluids. Interestingly IL-17 appeared to be proinflammatory and pro-mucinogenic, yet paradoxically is protective against hypoxia (79). Our study surprisingly shows the novel observation that TSLP and CCL20 are preferentially secreted by RSV-infected lower airway epithelial cells, perhaps providing information on how LRTI is associated with Th2 lymphocyte skewing, DC recruitment and Th17 activation.
Severe RSV infections produce a characteristic pathological pattern that includes epithelial necrosis, sloughing and mucous plugging of the small bronchioles, resulting clinically in hypoxia and hyper-aeration (12, 55, 56). Mucous plugging is a complex phenomenon determined by both viral and host factors. Although the RSV nonstructural protein NS2 has been demonstrated to induce shedding of bronchiolar epithelial cells (12), the mechanisms for enhanced mucin production in RSV infection are not well understood. Rodent models of RSV disease have not consistently shown high levels of mucin production, unless the animals have had prior allergic sensitization (80), or strains of RSV are used that selectively induce IL-13 production (81).
In this study, we observe that RSV-induced CCL20 production is restricted to the epithelium, and that it preferentially secreted by lower airway cells. Other elegant studies have shown that CCL20 plays a pathogenic role in the mouse model of infection. Here knockouts of the CCL20 receptor (CCR6) or CCL20 neutralization have shown that inhibition of the CCL20-CCR6 axis decreases RSV-induced MUC5a and Gob5 expression and Th2 responses (52). Our have demonstrated that CCL20 is the major biological protein inducing mucin production secreted from RSV-infected hSAECs. Interestingly, the molecular pathway producing MUC5A expression is mediated by cleavage of the EGFR ligand by the cell-surface ADAM17/TACE distintegrin (51). This previous study was unable to induce MUC production in primary airway epithelial cells; here we demonstrate both recombinant CCL20 and CCL20 in hSAEC CM induces MUC5A expression in phBECs, and that phBECs express CCR6R. The explanation for these different results may be due to cell-type differences in expression of the ADAM17/TACE distintegrin, or variability in CCR6 expression in cultured cells.
In summary, we apply quantitative, label-free mass spectrometry profiling to identify cell type-specific patterns in RSV-induced protein secretion that arises from the exosomal compartment. We validate the differential secretion patterns across multiple donors, and confirm our findings in a mouse model in vivo. We demonstrate that lower airway secretion of CCL20 is a mucin-promoting factor that may account for enhanced mucous plugging in distal airways in RSV LRTIs. These data provide insights into the pathogenesis of Th2 polarization and mucus plugging in this disease.
Supplementary Material
Acknowledgments
Research support was provided by the Sealy Center for Molecular Medicine, NIAID Signaling in Airway inflammation P01 AI068865 (ARB), UTMB CTSA UL1TR001439 (ARB), NIEHS P30 ES006676 (ARB), and NSF DMS-1361411/DMS-1361318 (ARB).
Core laboratory support was provided by the Sealy Center for Molecular Medicine Selected Reaction Monitoring facility and the UTMB Optical imaging and Histochemistry Facilities. We thank Dr. David Konkel for critically editing the manuscript.
Abbreviations used in this article
- CCL20
Chemokine (C-C Motif) Ligand 20
- CCL3-L1
chemokine (CC) ligand 3-like 1
- EHF
epithelial-specific ets homology factor
- FDR
false discovery rate
- GO
gene ontology
- GOCC
GO Cellular Component enrichment
- GSEA
gene set enrichment analysis
- hBEC
human bronchial epithelial cell
- hSAEC
human small airway epithelial cell
- LC-MS/MS
liquid chromatography - tandem mass spectrometry
- NSAF
normalized spectral abundance factor
- PCA
principal component analysis
- RSV
respiratory syncytial virus
- SID
stable isotopic dilution
- SAM
statistical analysis of microarray
- SRM
selected reaction monitoring
- Tert
human telomerase
- TSLP
thymic stromal lymphopoietin
- WCL
whole cell lysate
Footnotes
Disclosures
The authors have no financial conflicts of interest.
Author contributions
YXZ, MJ YQZ, HS and TI performed experiments. YXZ, RPG and ARB conceived and designed experiments. YXZ, MJ YQZ, HS, TI, RPG and ARB interpreted experiments. YXZ and ARB wrote the manuscript. All authors approved the final submitted manuscript.
References
- 1.Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, et al. The Burden of Respiratory Syncytial Virus Infection in Young Children. The New England Journal of Medicine. 2009;360(6):588–98. doi: 10.1056/NEJMoa0804877. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Easton AJ, Domachowske JB, Rosenberg HF. Animal Pneumoviruses: Molecular Genetics and Pathogenesis. Clinical Microbiology Reviews. 2004;17(2):390–412. doi: 10.1128/CMR.17.2.390-412.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Hall CB, Weinberg GA, Blumkin AK, Edwards KM, Staat MA, Schultz AF, Poehling KA, Szilagyi PG, Griffin MR, Williams JV, et al. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. 2013;132(2):e341–8. doi: 10.1542/peds.2013-0303. [DOI] [PubMed] [Google Scholar]
- 4.Collins PL, Graham BS. Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol. 2008;82(5):2040–55. doi: 10.1128/JVI.01625-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Zorc JJ, Hall CB. Bronchiolitis: Recent Evidence on Diagnosis and Management. Pediatrics (Evanston IL) 2010;125(2):342–9. doi: 10.1542/peds.2009-2092. [DOI] [PubMed] [Google Scholar]
- 6.Moore ML, Stokes KL, Hartert TV. The impact of viral genotype on pathogenesis and disease severity: respiratory syncytial virus and human rhinoviruses. Curr Opin Immunol. 2013;25(6):761–8. doi: 10.1016/j.coi.2013.09.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hall CB. Respiratory syncytial virus and parainfluenza virus. New England Journal of Medicine. 2001;344:1917–28. doi: 10.1056/NEJM200106213442507. [DOI] [PubMed] [Google Scholar]
- 8.Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980–1996. Journal of the American Medical Association. 1999;282:1440–6. doi: 10.1001/jama.282.15.1440. [DOI] [PubMed] [Google Scholar]
- 9.Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O’Brien KL, Roca A, Wright PF, Bruce N, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375(9725):1545–55. doi: 10.1016/S0140-6736(10)60206-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, Kjellman B. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med. 2005;171(2):137–41. doi: 10.1164/rccm.200406-730OC. [DOI] [PubMed] [Google Scholar]
- 11.Richardson LS, Belshe RB, Sly DL, London WT, Prevar DA, Camargo E, Chanock RM. Experimental respiratory syncytial virus pneumonia in cebus monkeys. Journal of Medical Virology. 1978;2(1):45–59. doi: 10.1002/jmv.1890020108. [DOI] [PubMed] [Google Scholar]
- 12.Liesman RM, Buchholz UJ, Luongo CL, Yang L, Proia AD, DeVincenzo JP, Collins PL, Pickles RJ. RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction. The Journal of Clinical Investigation. 2014;124(5):2219–33. doi: 10.1172/JCI72948. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Garofalo RP, Haeberle H. Epithelial regulation of innate immunity to respiratory syncytial virus. American Journal of Respiratory Cell and Molecular Biology. 2000;23:581–5. doi: 10.1165/ajrcmb.23.5.f204. [DOI] [PubMed] [Google Scholar]
- 14.Tian B, Zhang Y, Luxon BA, Garofalo RP, Casola A, Sinha M, Brasier AR. Identification of NF-kappaB-dependent gene networks in respiratory syncytial virus-infected cells. J Virol. 2002;76(13):6800–14. doi: 10.1128/JVI.76.13.6800-6814.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Zhang Y, Luxon BA, Casola A, Garofalo RP, Jamaluddin M, Brasier AR. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J Virol. 2001;75(19):9044–58. doi: 10.1128/JVI.75.19.9044-9058.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Bennett BL, Garofalo RP, Cron SG, Hosakote YM, Atmar RL, Macias CG, Piedra PA. Immunopathogenesis of respiratory syncytial virus bronchiolitis. J Infect Dis. 2007;195(10):1532–40. doi: 10.1086/515575. [DOI] [PubMed] [Google Scholar]
- 17.Holt PG, Strickland DH, Wikstrom ME, Jahnsen FL. Regulation of immunological homeostasis in the respiratory tract. Nature reviews Immunology. 2008;8(2):142–52. doi: 10.1038/nri2236. [DOI] [PubMed] [Google Scholar]
- 18.Choudhary S, Boldogh I, Brasier AR. Inside-out signaling pathways from nuclear reactive oxygen species control pulmonary innate immunity. Journal of innate immunity. 2016 doi: 10.1159/000442254. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Whitsett JA, Alenghat T. Respiratory epithelial cells orchestrate pulmonary innate immunity. Nat Immunol. 2015;16(1):27–35. doi: 10.1038/ni.3045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Olzewska B, Casola A, Saito T, Alam R, Crowe S, Mei F, Ogra PL, Garofalo R. Cell-specific expression of RANTES, MCP-1, and MIP-1a by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. Journal of Virology. 1998;72:4756–64. doi: 10.1128/jvi.72.6.4756-4764.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Welliver TP, Garofalo RP, Hosakote Y, Hintz KH, Avendano L, Sanchez K, Velozo L, Jafri H, Chavez-Bueno S, Ogra PL, et al. Severe Human Lower Respiratory Tract Illness Caused by Respiratory Syncytial Virus and Influenza Virus Is Characterized by the Absence of Pulmonary Cytotoxic Lymphocyte Responses. The Journal of Infectious Diseases. 2007;195(8):1126–36. doi: 10.1086/512615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, Pollack J, Peyton M, Zou Y, Kurie JM, Dimaio JM, et al. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res. 2004;64(24):9027–34. doi: 10.1158/0008-5472.CAN-04-3703. [DOI] [PubMed] [Google Scholar]
- 23.Kalita M, Tian B, Gao B, Choudhary S, Wood TG, Carmical JR, Boldogh I, Mitra S, Minna JD, Brasier AR. Systems Approaches to Modeling Chronic Mucosal Inflammation. BioMed Research International. 2013:505864. doi: 10.1155/2013/505864. [DOI] [PMC free article] [PubMed]
- 24.Garofalo R, Mei F, Manganaro M, Espejo R, Ogra PL, Reyes VE. Upregulation of class I major histocompatibility complex (MHC) molecules on respiratory syncytial virus (RSV)-infected airway epithelial cells. American Journal of Respiratory and Critical Care Medicine. 1994;149:A987. [Google Scholar]
- 25.Kalita MK, Sargsyan K, Tian B, Paulucci-Holthauzen A, Najm HN, Debusschere BJ, Brasier AR. Sources of cell-to-cell variability in canonical nuclear factor-kappaB (NF-kappaB) signaling pathway inferred from single cell dynamic images. J Biol Chem. 2011;286(43):37741–57. doi: 10.1074/jbc.M111.280925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Brasier AR, Tian B, Jamaluddin M, Kalita MK, Garofalo RP, Lu M. RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection. J Virol. 2011;85(22):11752–69. doi: 10.1128/JVI.05360-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Wessel D, Flugge UI. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem. 1984;138(1):141–3. doi: 10.1016/0003-2697(84)90782-6. [DOI] [PubMed] [Google Scholar]
- 28.Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26(12):1367–72. doi: 10.1038/nbt.1511. [DOI] [PubMed] [Google Scholar]
- 29.Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Molecular & cellular proteomics : MCP. 2014;13(9):2513–26. doi: 10.1074/mcp.M113.031591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98(9):5116–21. doi: 10.1073/pnas.091062498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Zybailov B, Mosley AL, Sardiu ME, Coleman MK, Florens L, Washburn MP. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J Proteome Res. 2006;5(9):2339–47. doi: 10.1021/pr060161n. [DOI] [PubMed] [Google Scholar]
- 32.Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–50. doi: 10.1073/pnas.0506580102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Keerthikumar S, Chisanga D, Ariyaratne D, Al Saffar H, Anand S, Zhao K, Samuel M, Pathan M, Jois M, Chilamkurti N, et al. ExoCarta: A Web-Based Compendium of Exosomal Cargo. J Mol Biol. 2016;428(4):688–92. doi: 10.1016/j.jmb.2015.09.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Zhao Y, Brasier AR. Applications Of Selected Reaction Monitoring (SRM)-Mass Spectrometry (MS) For Quantitative Measurement Of Signaling Pathways. Methods. 2013 doi: 10.1016/j.ymeth.2013.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Haeberle HA, Takizawa R, Casola A, Brasier AR, Dieterich HJ, Van Rooijen N, Gatalica Z, Garofalo RP. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. J Infect Dis. 2002;186(9):1199–206. doi: 10.1086/344644. [DOI] [PubMed] [Google Scholar]
- 36.Gao B, Huang C, Sullivan JP, Spinola M, Gabriela Raso M, Wistuba I, Shay J, Minna JD. Immortalization of human small airway epithelial cells with characteristics of bronchioalveolar stem cells. FASEB J. 2009;23 Meeting Abstract. [Google Scholar]
- 37.Tian B, Zhao Y, Kalita M, Edeh CB, Paessler S, Casola A, Teng MN, Garofalo RP, Brasier AR. CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells. J Virol. 2013;87(12):7075–92. doi: 10.1128/JVI.03399-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Fang L, Choudhary S, Tian B, Boldogh I, Yang C, Ivanciuc T, Ma Y, Garofalo RP, Brasier AR. Ataxia Telangiectasia Mutated Kinase Mediates NF-kappaB Serine 276 Phosphorylation and Interferon Expression via the IRF7-RIG-I Amplification Loop in Paramyxovirus Infection. J Virol. 2015;89(5):2628–42. doi: 10.1128/JVI.02458-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Zhang L, Peeples ME, Boucher RC, Collins PL, Pickles RJ. Respiratory Syncytial Virus Infection of Human Airway Epithelial Cells Is Polarized, Specific to Ciliated Cells, and without Obvious Cytopathology. The Journal of Virology. 2002;76(11):5654–66. doi: 10.1128/JVI.76.11.5654-5666.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Thomas KW, Monick MM, Staber JM, Yarovinsky T, Carter AB, Hunninghake GW. Respiratory Syncytial Virus Inhibits Apoptosis and Induces NF-kappa B Activity through a Phosphatidylinositol 3-Kinase-dependent Pathway. Journal of Biological Chemistry. 2002;277(1):492–501. doi: 10.1074/jbc.M108107200. [DOI] [PubMed] [Google Scholar]
- 41.Liu H, Sadygov RG, Yates JR., III A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem. 2004;76(14):4193–201. doi: 10.1021/ac0498563. [DOI] [PubMed] [Google Scholar]
- 42.Old WM, Meyer-Arendt K, Aveline-Wolf L, Pierce KG, Mendoza A, Sevinsky JR, Resing KA, Ahn NG. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Molecular & cellular proteomics : MCP. 2005;4(10):1487–502. doi: 10.1074/mcp.M500084-MCP200. [DOI] [PubMed] [Google Scholar]
- 43.Paoletti AC, Parmely TJ, Tomomori-Sato C, Sato S, Zhu D, Conaway RC, Conaway JW, Florens L, Washburn MP. Quantitative proteomic analysis of distinct mammalian Mediator complexes using normalized spectral abundance factors. Proc Natl Acad Sci U S A. 2006;103(50):18928–33. doi: 10.1073/pnas.0606379103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Nickel W, Rabouille C. Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol. 2009;10(2):148–55. doi: 10.1038/nrm2617. [DOI] [PubMed] [Google Scholar]
- 45.Zhao Y, Tian B, Edeh CB, Brasier AR. Quantitation of the dynamic profiles of the innate immune response using multiplex selected reaction monitoring-mass spectrometry. Molecular & cellular proteomics : MCP. 2013;12:1513–29. doi: 10.1074/mcp.M112.023465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Zhao YX, Widen SG, Jamaluddin M, Tian B, Wood TG, Edeh CB, Brasier AR. Quantification of Activated NF-kappa B/RelA Complexes Using ssDNA Aptamer Affinity - Stable Isotope Dilution-Selected Reaction Monitoring-Mass Spectrometry. Molecular & Cellular Proteomics. 2011;10(6) doi: 10.1074/mcp.M111.008771. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proceedings of the National Academy of Sciences. 2003;100(12):6940–5. doi: 10.1073/pnas.0832254100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Kramer A, Green J, Pollard J, Jr, Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014;30(4):523–30. doi: 10.1093/bioinformatics/btt703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Lee HC, Headley MB, Loo YM, Berlin A, Gale M, Jr, Debley JS, Lukacs NW, Ziegler SF. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. The Journal of allergy and clinical immunology. 2012;130(5):1187–96. e5. doi: 10.1016/j.jaci.2012.07.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Reche PA, Soumelis V, Gorman DM, Clifford T, Liu M-r, Travis M, Zurawski SM, Johnston J, Liu Y-J, Spits H, et al. Human Thymic Stromal Lymphopoietin Preferentially Stimulates Myeloid Cells. The Journal of Immunology. 2001;167(1):336–43. doi: 10.4049/jimmunol.167.1.336. [DOI] [PubMed] [Google Scholar]
- 51.Kim S, Lewis C, Nadel JA. CCL20/CCR6 feedback exaggerates epidermal growth factor receptor-dependent MUC5AC mucin production in human airway epithelial (NCI-H292) cells. Journal of immunology (Baltimore, Md : 1950) 2011;186(6):3392–400. doi: 10.4049/jimmunol.1003377. [DOI] [PubMed] [Google Scholar]
- 52.Kallal LE, Schaller MA, Lindell DM, Lira SA, Lukacs NW. CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC. Eur J Immunol. 2010;40(4):1042–52. doi: 10.1002/eji.200939778. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Hull J, Rowlands K, Lockhart E, Moore C, Sharland M, Kwiatkowski D. Variants of the Chemokine Receptor CCR5 Are Associated with Severe Bronchiolitis Caused by Respiratory Syncytial Virus. Journal of Infectious Diseases. 2003;188(6):904–7. doi: 10.1086/377587. [DOI] [PubMed] [Google Scholar]
- 54.Roy MG, Livraghi-Butrico A, Fletcher AA, McElwee MM, Evans SE, Boerner RM, Alexander SN, Bellinghausen LK, Song AS, Petrova YM, et al. Muc5b is required for airway defence. Nature. 2014;505(7483):412–6. doi: 10.1038/nature12807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Aherne WT, Bird T, Court SDB, Gardner PS, McQuillin J. Pathological changes in virus infections of the lower respiratory tract in children. Journal Clinical Pathology. 1970;23:7–18. doi: 10.1136/jcp.23.1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Ferris JA, Aherne WA, Locke WS. Sudden and unexpected deaths to infants: histology and virology. British Medical Journal. 1973;2:439–49. doi: 10.1136/bmj.2.5864.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Haeberle HA, Casola A, Gatalica Z, Petronella S, Dieterich HJ, Ernst PB, Brasier AR, Garofalo RP. IkappaB kinase is a critical regulator of chemokine expression and lung inflammation in respiratory syncytial virus infection. J Virol. 2004;78(5):2232–41. doi: 10.1128/JVI.78.5.2232-2241.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Bertolusso R, Tian B, Zhao Y, Vergara LA, Sabree A, Iwanaszko M, Lipniacki T, Brasier A, Kimmel M. Dynamic Cross Talk Model Of The Epithelial Innate Immune Response To Double-Stranded Rna Stimulation: Coordinated Dynamics Emerging From Cell-Level Noise. PLoS ONE. 2014;9(4):e93396. doi: 10.1371/journal.pone.0093396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Jamaluddin M, Wang S, Garofalo RP, Elliott T, Casola A, Baron S, Brasier AR. IFN-beta mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells. American journal of physiology Lung cellular and molecular physiology. 2001;280(2):L248–57. doi: 10.1152/ajplung.2001.280.2.L248. [DOI] [PubMed] [Google Scholar]
- 60.Bao X, Liu T, Shan Y, Li K, Garofalo RP, Casola A. Human metapneumovirus glycoprotein G inhibits innate immune responses. PLoS Pathog. 2008;4(5):e1000077. doi: 10.1371/journal.ppat.1000077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Bao X, Liu T, Spetch L, Kolli D, Garofalo RP, Casola A. Airway epithelial cell response to human metapneumovirus infection. Virology (New York NY) 2007;368(1):91–101. doi: 10.1016/j.virol.2007.06.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Knight DA, Holgate ST. The airway epithelium: structural and functional properties in health and disease. Respirology. 2003;8(4):432–46. doi: 10.1046/j.1440-1843.2003.00493.x. [DOI] [PubMed] [Google Scholar]
- 63.Brasier AR, Spratt H, Wu Z, Boldogh I, Zhang Y, Garofalo RP, Casola A, Pashmi J, Haag A, Luxon B, et al. Nuclear heat shock response and novel nuclear domain 10 reorganization in respiratory syncytial virus-infected a549 cells identified by high-resolution two-dimensional gel electrophoresis. J Virol. 2004;78(21):11461–76. doi: 10.1128/JVI.78.21.11461-11476.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Munday DC, Emmott E, Surtees R, Lardeau CH, Wu W, Duprex WP, Dove BK, Barr JN, Hiscox JA. Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus. Molecular & cellular proteomics : MCP. 2010;9(11):2438–59. doi: 10.1074/mcp.M110.001859. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Ternette N, Wright C, Kramer HB, Altun M, Kessler BM. Label-free quantitative proteomics reveals regulation of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) and 5′-3′-exoribonuclease 2 (XRN2) during respiratory syncytial virus infection. Virology journal. 2011;8(1):1–13. doi: 10.1186/1743-422X-8-442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Persson BD, Jaffe AB, Fearns R, Danahay H. Respiratory syncytial virus can infect basal cells and alter human airway epithelial differentiation. PLoS One. 2014;9(7):e102368. doi: 10.1371/journal.pone.0102368. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Meissner F, Scheltema RA, Mollenkopf H-J, Mann M. Direct Proteomic Quantification of the Secretome of Activated Immune Cells. Science. 2013;340(6131):475–8. doi: 10.1126/science.1232578. [DOI] [PubMed] [Google Scholar]
- 68.Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nature reviews Immunology. 2002;2(8):569–79. doi: 10.1038/nri855. [DOI] [PubMed] [Google Scholar]
- 69.Levanen B, Bhakta NR, Torregrosa Paredes P, Barbeau R, Hiltbrunner S, Pollack JL, Skold CM, Svartengren M, Grunewald J, Gabrielsson S, et al. Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patients. The Journal of allergy and clinical immunology. 2013;131(3):894–903. doi: 10.1016/j.jaci.2012.11.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Torregrosa Paredes P, Esser J, Admyre C, Nord M, Rahman QK, Lukic A, Radmark O, Gronneberg R, Grunewald J, Eklund A, et al. Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma. Allergy. 2012;67(7):911–9. doi: 10.1111/j.1398-9995.2012.02835.x. [DOI] [PubMed] [Google Scholar]
- 71.Kesimer M, Scull M, Brighton B, DeMaria G, Burns K, O’Neal W, Pickles RJ, Sheehan JK. Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. The FASEB Journal. 2009;23(6):1858–68. doi: 10.1096/fj.08-119131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Kulshreshtha A, Ahmad T, Agrawal A, Ghosh B. Proinflammatory role of epithelial cell-derived exosomes in allergic airway inflammation. The Journal of allergy and clinical immunology. 2013;131(4):1194–203. 203.e1–14. doi: 10.1016/j.jaci.2012.12.1565. [DOI] [PubMed] [Google Scholar]
- 73.Komiya Y, Habas R. Wnt signal transduction pathways. Organogenesis. 2008;4(2):68–75. doi: 10.4161/org.4.2.5851. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Sigurs N, Aljassim F, Kjellman B, Robinson PD, Sigurbergsson F, Bjarnason R, Gustafsson PM. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax. 2010;65(12):1045–52. doi: 10.1136/thx.2009.121582. [DOI] [PubMed] [Google Scholar]
- 75.Sigurs N, Bjarnason R, Sigurbergsson F. Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy. Acta Pediatr. 1994;83:1151–5. doi: 10.1111/j.1651-2227.1994.tb18269.x. [DOI] [PubMed] [Google Scholar]
- 76.Allakhverdi Z, Comeau MR, Jessup HK, Yoon BR, Brewer A, Chartier S, Paquette N, Ziegler SF, Sarfati M, Delespesse G. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med. 2007;204(2):253–8. doi: 10.1084/jem.20062211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Ziegler SF, Roan F, Bell BD, Stoklasek TA, Kitajima M, Han H. The biology of thymic stromal lymphopoietin (TSLP) Adv Pharmacol. 2013;66:129–55. doi: 10.1016/B978-0-12-404717-4.00004-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Yamazaki T, Yang XO, Chung Y, Fukunaga A, Nurieva R, Pappu B, Martin-Orozco N, Kang HS, Ma L, Panopoulos AD, et al. CCR6 regulates the migration of inflammatory and regulatory T cells. Journal of immunology (Baltimore, Md : 1950) 2008;181(12):8391–401. doi: 10.4049/jimmunol.181.12.8391. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Mangodt TC, Van Herck MA, Nullens S, Ramet J, De Dooy JJ, Jorens PG, De Winter BY. The role of Th17 and Treg responses in the pathogenesis of RSV infection. Pediatr Res. 2015;78(5):483–91. doi: 10.1038/pr.2015.143. [DOI] [PubMed] [Google Scholar]
- 80.Hashimoto K, Graham BS, Ho SB, Adler KB, Collins RD, Olson SJ, Zhou W, Suzutani T, Jones PW, Goleniewska K, et al. Respiratory syncytial virus in allergic lung inflammation increases Muc5ac and gob-5. Am J Respir Crit Care Med. 2004;170(3):306–12. doi: 10.1164/rccm.200301-030OC. [DOI] [PubMed] [Google Scholar]
- 81.Moore ML, Chi MH, Luongo C, Lukacs NW, Polosukhin VV, Huckabee MM, Newcomb DC, Buchholz UJ, Crowe JE, Jr, Goleniewska K, et al. A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J Virol. 2009;83(9):4185–94. doi: 10.1128/JVI.01853-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.